43 results on '"Samol, J."'
Search Results
2. P1.23-03 Amplicon-Based Liquid Biopsy Prospectively Detects More Tissue-Confirmed Guideline-Recommended Biomarkers in Lung Cancer
3. PP01.74 Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC
4. LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722
5. 652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)
6. 100P Physician perceptions of testing practices in patients with early and advanced stage EGFR mutation-positive (EGFRm) NSCLC: A global survey
7. 1046P Phase I/II open-label study on an anti-GPC3 T cell engager, SAR444200, in patients with advanced solid tumors: Preliminary dose escalation results
8. 26P Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries
9. Germline BRCA1/2 testing: Trend in Tan Tock Seng Hospital Singapore
10. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization
11. Favourable outcome for patients with myeloid disorders treated with fludarabine–melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies
12. To determine if there is a difference in outcomes for patients undergoing synchronous primary colorectal cancer and liver resection with or without preoperative treatment
13. 378P - Germline BRCA1/2 testing: Trend in Tan Tock Seng Hospital Singapore
14. The United Kingdom (Uk) National Cancer Research Network (Ncrn) Chemotherapy and Pharmacy Advisory Service (Cpas): Service Development and Quality Control Experience of Pharmacy Aspects in Clinical Research Protocols
15. Overestimation of carboplatin doses is avoided by radionuclide GFR measurement
16. BMJ
17. Unexpected finding on staging bone marrow aspirate for Hodgkin's lymphoma
18. Oxaliplatin-induced coronary artery spasm: first report of an important side-effect
19. Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma
20. 1408P - The United Kingdom (Uk) National Cancer Research Network (Ncrn) Chemotherapy and Pharmacy Advisory Service (Cpas): Service Development and Quality Control Experience of Pharmacy Aspects in Clinical Research Protocols
21. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
22. Fibrosis in Hodgkin's disease: fibrogenesis, fibrolysis, and factors contributing to their regulation
23. Machine learning unveils an immune-related DNA methylation profile in germline DNA from breast cancer patients.
24. Beyond a vestigial organ: effects of the appendix on gut microbiome and colorectal cancer.
25. Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.
26. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
27. Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
28. Molecular testing in non-small cell lung cancer: A consensus recommendation.
29. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
30. Early COVID-19 booster is beneficial in cancer patients.
31. Correction: Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
32. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
33. Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
34. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
35. Lung Cancer in Singapore.
36. Remote Right Main Pulmonary Bronchus Bronchopleural Fistula Formation after Microwave Ablation of Lung Tumor.
37. Outcome of advanced lung cancer with central airway obstruction versus without central airway obstruction.
38. Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service.
39. Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study.
40. Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma.
41. The efficacy of rHuEPO in cancer-related anaemia.
42. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
43. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.